Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2510]

UK NICE guidance recommends degarelix for the treatment of advanced hormone-dependent prostate cancer only in people with impending spinal cord compression

UK NICE guidance recommends degarelix for the treatment of advanced hormone-dependent prostate cancer only in...

Chemotherapy before or after surgery for high-risk bladder cancer improves survival but is not routinely administered

Chemotherapy before or after surgery for high-risk bladder cancer improves survival but is not routinely...

A quarter of men drop out of prostate cancer monitoring

A quarter of men drop out of prostate cancer monitoring

Therapeutic options and bladder-preserving strategies in bladder cancer reviewed

Therapeutic options and bladder-preserving strategies in bladder cancer reviewed

New figures show men are unaware of cancer risk

New figures show men are unaware of cancer risk

Study finds prostate cancer tests underestimate disease in half of cases

Study finds prostate cancer tests underestimate disease in half of cases

AACR: Targeted investigational therapy shows early promise against multiple cancer types

AACR: Targeted investigational therapy shows early promise against multiple cancer types

AACR: Blood-based biomarker may identify prostate cancers that will be resistant to enzalutamide

AACR: Blood-based biomarker may identify prostate cancers that will be resistant to enzalutamide

ESTRO: Six months hormonal treatment in addition to radiotherapy improves survival for men with localised prostate cancer

ESTRO: Six months hormonal treatment in addition to radiotherapy improves survival for men with localised prostate...

ESTRO: Brachytherapy helps maintain erectile function in prostate cancer patients without compromising treatment outcomes

ESTRO: Brachytherapy helps maintain erectile function in prostate cancer patients without compromising treatment...

More from ecancer